Compounds
Phleomycins
Producing organism:
Streptomyces verticillus
Activity:
Antitumor
Clinical use:
-
Class no:
10 Reference(s)
Please scroll horizontally.
Title | Author | Journal | Year | Volume | Page |
---|---|---|---|---|---|
Inhibition of resistant dysentery bacilli by phleomycin. | T. Takeuchi; M. Ishizuka; Y. Yamzaki; H. Umezawa | J. Antibiotics | 1963 | 16 | 172 |
Separation of phleomycin components and their properties. | T. Ikekawa; F. Iwami; H. Hiranaka; H. Umezawa | J. Antibiotics | 1964 | 17 | 194-199 |
Studies on antitumor effect of phleomycin. | H. Umezawa; M. Hori; M. Ishizuka; T. Takeuchi | J. Antibiotics | 1962 | 15 | 274-275 |
Studies on antitumor activity, antimicrobial activity and toxicity of phleomycin. | M. Ishizuka; H. Takayamma; T. Takeuchi; H. Umezawa | J. Antibiotics | 1966 | 19 | 260-271 |
Modes of action of phleomycin, bleomycin and formycin on HeLa S3 cells in synchronized culture. | T. Kunimoto; M. Hori; H. Umezawa | J. Antibiotics | 1967 | 20 | 277-281 |
The structure of the sulfur-containing chromophore of phleomycin, and chemical transformation of phleomycin to bleomycin. | T. Takita; Y. Muraoka; A. Fujii; H. Itoh; K. Maeda; H. Umezawa | J. Antibiotics | 1972 | 25 | 197-199 |
The chemistry of bleomycin. IX. The structures of bleomycin and phleomycin. | T. Takita; Y. Muraoka; T. Yoshioka; A. Fujii; K. Maeda; H. Umezawa | J. Antibiotics | 1972 | 25 | 755-758 |
Chemistry of bleomycin. XIX. Revised structures of bleomycin and phleomycin. | T. Takita; Y.Muraoka; T. Nakatani; A. Fujii; Y.Umezawa; H. Naganawa; H. Umezawa | J. Antibiotics | 1978 | 31 | 801-804 |
Bleomycin-phleomycin group antibiotics. | T. Takita | Advances in Natural Products Chemistry (S. Natori et al. eds.) Kodansha Scientific Co. | 1981 | 29-38 | |
Bleomycin-phleomycin group antibiotics. | T. Takita | Advances in Natural Products Chemistry (S. Natori, N. Ikegawa, M. Suzuki, eds.)Kodansha Scientific | 1981 | 29-38 |